company background image
NIPH

Nile for Pharmaceuticals and Chemical Industries CASE:NIPH Stock Report

Last Price

ج.م43.00

Market Cap

ج.م435.4m

7D

-2.6%

1Y

21.1%

Updated

21 Sep, 2023

Data

Company Financials

The Nile Co. for Pharmaceuticals and Chemical Industries

CASE:NIPH Stock Report

Mkt Cap: ج.م435.4m

NIPH Stock Overview

The Nile Co. for Pharmaceuticals and Chemical Industries develops, produces, and sells pharmaceutical products primarily in the Middle East.

NIPH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health3/6
Dividends3/6

The Nile Co. for Pharmaceuticals and Chemical Industries Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nile for Pharmaceuticals and Chemical Industries
Historical stock prices
Current Share Priceج.م43.00
52 Week Highج.م48.99
52 Week Lowج.م28.44
Beta0.16
1 Month Change-7.90%
3 Month Change7.53%
1 Year Change21.09%
3 Year Change32.47%
5 Year Change320.74%
Change since IPO187.95%

Recent News & Updates

Recent updates

Shareholder Returns

NIPHEG PharmaceuticalsEG Market
7D-2.6%-0.6%3.2%
1Y21.1%13.8%77.1%

Return vs Industry: NIPH exceeded the EG Pharmaceuticals industry which returned 13.7% over the past year.

Return vs Market: NIPH underperformed the EG Market which returned 75% over the past year.

Price Volatility

Is NIPH's price volatile compared to industry and market?
NIPH volatility
NIPH Average Weekly Movement5.3%
Pharmaceuticals Industry Average Movement3.7%
Market Average Movement4.5%
10% most volatile stocks in EG Market7.6%
10% least volatile stocks in EG Market2.6%

Stable Share Price: NIPH is not significantly more volatile than the rest of EG stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: NIPH's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1962n/aKhaled Salah Hagaghttps://www.nilepharma.com.eg

The Nile Co. for Pharmaceuticals and Chemical Industries develops, produces, and sells pharmaceutical products primarily in the Middle East. The company offers prescription pharmaceutical products, including tablets, capsules, dry syrups, syrups and suspensions, ointments, gels and creams, suppositories, ampoules, drops, parenteral, sachets, biotechnological products, lyophilized products, sterile antibiotic vials, lotions, shampoos, and solutions. It also provides non-prescription pharmaceutical products, such as analgesic and anti-inflammatory, antihistaminic, anthelmintic, antibacterial, antifungal, cardiovascular disorders, central nervous system and antiparkinsonism drugs, oral cavity products, respiratory system disorders, urinary tract disorders, endocrine glands disorders, gastrointestinal tract disorders, muscle relaxants, topical otic and nasal preparations, topical ophthalmological preparations, dermatological preparations, women and men healthcare products, osteoporosis, pediatrics, cosmetics, antiseptics, and immunological products, as well as vitamins and minerals.

The Nile Co. for Pharmaceuticals and Chemical Industries Fundamentals Summary

How do Nile for Pharmaceuticals and Chemical Industries's earnings and revenue compare to its market cap?
NIPH fundamental statistics
Market Capج.م435.38m
Earnings (TTM)ج.م94.03m
Revenue (TTM)ج.م936.31m

4.6x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
NIPH income statement (TTM)
Revenueج.م936.31m
Cost of Revenueج.م699.81m
Gross Profitج.م236.50m
Other Expensesج.م142.47m
Earningsج.م94.03m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)9.29
Gross Margin25.26%
Net Profit Margin10.04%
Debt/Equity Ratio70.1%

How did NIPH perform over the long term?

See historical performance and comparison

Dividends

6.9%

Current Dividend Yield

32%

Payout Ratio